An efficient and commercial phosphorylation process of a complex alcohol, such as secondary and tertiary alcohols, with P.sub.4O.sub.10 at high temperatures, and a product obtained by the process.

An efficient and commercial phosphorylation process of a complex alcohol, such as secondary and tertiary alcohols, with P.sub.4O.sub.10 at high temperatures, and a product obtained by the process.

A flame retardant for thermosetting resin containing an aromatic phosphoric acid ester represented by the general formula (I):

##STR00001##

wherein R.sup.1 to R.sup.4 each independently represent a hydrogen atom, a C.sub.1-4 alkyl group, or a C.sub.1-4 alkoxy group; R.sup.5, R.sup.6, and R.sup.9 each independently represent a C.sub.1-10 alkyl group or a C.sub.1-10alkoxy group; R.sup.7 and R.sup.8 each independently represent a C.sub.1-4 alkyl group or a C.sub.1-4 alkoxy group; n represents an integer of 1 to 10; n.sup.1 and n.sup.2 each independently represent an integer of 0 to 3; m.sup.1 and m.sup.2 each independently represent an integer of 0 to 4; p represents an integer of 0 to 26; and k represents an integer of 1 to 12; and when p is 2 or more, any two substituents R.sup.9 may be bonded to each other, and may be bonded to a carbon atom(s) of a ring to which the above substituents R.sup.9 are bonded, forming another ring.

A process a process of forming a non-halogenated flame retardant (FR) hindered amine light stabilizer (HALS) cross-linker is disclosed. The process includes forming a mixture that includes a first molecule having a hindered amine group. The first molecule corresponds to a functionalized 2,2,6,6-tetramethylpiperidine (TMP) molecule. The process also includes forming the non-halogenated FR HALS cross-linker via a chemical reaction of the first molecule a second molecule. The second molecule includes a phosphoryl group, a chloride group, and at least one cross-linkable (CL) moiety.

Disclosed are a near-infrared absorbing composition, an optical structure, and a camera module and an electronic device including the same. The near-infrared absorbing composition includes a copper complex represented by Chemical Formula 1.

##STR00001##

Definitions of Chemical Formula 1 are the same as described in the detailed description.

The present invention relates to a non-aqueous electrolyte for a lithium secondary battery and a lithium secondary battery comprising same. The non-aqueous electrolyte comprises: a non-aqueous organic solvent; a lithium salt; a first additive containing at least one compound among compounds represented by chemical formulas 1 to 4; and a second additive containing at least one compound among compounds represented by chemical formula 5 or 6.

Disclosed are a near-infrared absorbing composition, an optical structure, and a camera module and an electronic device including the same. The near-infrared absorbing composition includes a copper complex represented by Chemical Formula 1.

(L.sup.1)-Cu-(L.sup.2)n [Chemical Formula 1]

Definitions of Chemical Formula 1 are described in the detailed description.

A battery including an anode, a cathode, a separator, and a liquid electrolyte including a lithium salt, a non-aqueous solvent, and an additive compound including a functionalized matrix having a polymer or copolymer or silica. The cathode material can be an NMC or LCO material. The electrode formed from the cathode or anode material can include a matrix additive. The matrix additive can be adhered to the separator or other inert component of the battery.

An ionic compound, an absorbent and an absorption device are provided. The ionic compound has a structure represented by Formula (I):

AB.sub.n, Formula (I)

wherein A is

##STR00001##

B is

##STR00002##

R.sup.1, R.sup.2, R.sup.3, R.sup.4, R.sup.5, and R.sup.6 are independently H, C.sub.1-6 alkyl group; and n is 1 or 2.

The present disclosure relates generally to certain compounds, pharmaceutical compositions comprising said compounds, and methods of making and using said compounds and pharmaceutical compositions. The compounds and compositions provided herein may be used for the treatment or prevention of a Retroviridae infection, including an HIV infection.